INSMED INC's ticker is INSM and the CUSIP is 457669307. A total of 213 filers reported holding INSMED INC in Q2 2022. The put-call ratio across all filers is 0.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $380,000 | -5.2% | 17,644 | -13.3% | 0.14% | +3.6% |
| Q2 2022 | $401,000 | -20.9% | 20,344 | -5.8% | 0.14% | -10.8% |
| Q1 2022 | $507,000 | -13.8% | 21,594 | 0.0% | 0.16% | +1.9% |
| Q4 2021 | $588,000 | +4.6% | 21,594 | +5.8% | 0.15% | +0.7% |
| Q3 2021 | $562,000 | +2.0% | 20,414 | +5.5% | 0.15% | -1.9% |
| Q2 2021 | $551,000 | -10.1% | 19,344 | +7.5% | 0.16% | -17.0% |
| Q1 2021 | $613,000 | -1.3% | 17,994 | -3.5% | 0.19% | -3.6% |
| Q4 2020 | $621,000 | -11.7% | 18,644 | -14.7% | 0.20% | -24.4% |
| Q3 2020 | $703,000 | +45.5% | 21,864 | +24.8% | 0.26% | +35.1% |
| Q2 2020 | $483,000 | – | 17,524 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Asymmetry Capital Management, L.P. | 250,584 | $4,420,000 | 9.48% |
| Palo Alto Investors LP | 7,239,649 | $127,707,000 | 8.51% |
| Foresite Capital Management IV, LLC | 1,429,518 | $25,217,000 | 8.15% |
| First Light Asset Management, LLC | 1,294,743 | $22,839,000 | 3.45% |
| Foresite Capital Management II, LLC | 915,016 | $16,141,000 | 3.41% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 356,600 | $6,287,000 | 2.90% |
| ACUTA CAPITAL PARTNERS, LLC | 220,000 | $3,881,000 | 2.80% |
| EMERALD ADVISERS, LLC | 984,987 | $17,375,000 | 0.81% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 911,936 | $16,087,000 | 0.71% |
| Rock Springs Capital Management LP | 890,000 | $15,700,000 | 0.63% |